Cornerstone Capital, Inc. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cornerstone Capital, Inc. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,219,305
-31.7%
110,1450.0%0.15%
-29.0%
Q2 2023$1,785,450
-30.7%
110,145
-28.8%
0.21%
-33.4%
Q1 2023$2,575,006
+96.6%
154,655
+11.0%
0.31%
+85.1%
Q4 2022$1,309,937
+234.2%
139,355
-3.2%
0.17%
+205.5%
Q3 2022$392,000
-2.5%
143,980
+3.5%
0.06%
+5.8%
Q2 2022$402,000
-0.7%
139,140
+3.0%
0.05%
+15.6%
Q1 2022$405,000
-27.9%
135,045
+10.5%
0.04%
-25.0%
Q4 2021$562,000
-26.8%
122,2200.0%0.06%
-32.6%
Q3 2021$768,000
-4.7%
122,220
-9.2%
0.09%
-2.2%
Q2 2021$806,000
-4.6%
134,620
+0.7%
0.09%
-10.8%
Q1 2021$845,000
+16.9%
133,645
+4.0%
0.10%
+9.7%
Q4 2020$723,000
-1.0%
128,465
+2.4%
0.09%
-11.4%
Q3 2020$730,000
-11.6%
125,465
+9.5%
0.10%
-25.5%
Q2 2020$826,000
+57.9%
114,613
+2.5%
0.14%
+29.4%
Q1 2020$523,000
-73.5%
111,775
-54.5%
0.11%
-60.8%
Q4 2019$1,971,000
+15.5%
245,796
-0.9%
0.28%
+4.5%
Q3 2019$1,707,000
-17.5%
248,125
-0.4%
0.27%
-17.9%
Q2 2019$2,068,000
-15.0%
249,125
+1.8%
0.32%
-19.4%
Q1 2019$2,433,000
+49.6%
244,800
+15.1%
0.40%
+38.6%
Q4 2018$1,626,000
-48.2%
212,600
+18.0%
0.29%
-39.2%
Q3 2018$3,138,000
+127.2%
180,121
+23.8%
0.48%
+103.0%
Q2 2018$1,381,000
+264.4%
145,500
+67.9%
0.24%
+279.0%
Q1 2018$379,000
+7.7%
86,6500.0%0.06%
+3.3%
Q4 2017$352,00086,6500.06%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders